Shanghai
China
Government of the People's Republic of China - Shanghai Changzheng Hospital
Non-small cell lung cancer (NSCLC), EGFR-Tyrosine kinase inhibitors (TKIs), Oligo-residual disease (ORD), Consolidative ablation